Subgroup analyses showed significant difference in FPG reduction between the exenatide group (1.02 mmol/L, 1.38 to 0.67, I 2 = 0%, P = 0.49) and sitagliptin group, and a significant reduction in liraglutide group compared to sitagliptin groups (1.14 mmol/L, 1.40 to 0.88, I 2 = 0%, P = 0.56) as well
1 However, despite this surge in interest and the compelling narrative equating it with Ozempic, the central scientific question remains: Is there clinical and molecular evidence that justifies the comparison of Berberine to semaglutide
Common Peptides Used in Therapy Thymosin Beta-4 (TB-500) : Known for its regenerative properties, TB-500 is often used to accelerate wound healing and reduce inflammation
Drmic D, Kolenc D, Ilic S, et al
And, the more serious side effects, such as blood clots or congestive heart failure, are likely to occur in individuals who are already treating a preexisting condition, have heart conditions, or in those who are genetically predisposed to these conditions